Alexandra Karl
Family · Massapequa, NYNPI 1639658206
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 459 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Johnson & Johnson at 24.0% of the total. Among family clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 459 payments — averaging $25.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$3K
- Amgen$2K
- AbbVie$1K
- UCB, Inc.$1K
- Mallinckrodt Hospital Products Inc.$848
- Novartis$526
- plus $3K from 16 others
What the payments were for
- Food & beverage$11,45997%
- Education$3053%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(3 entities) | 93 | $2,829 |
| Amgen(2 entities) | 64 | $2,000 |
| AbbVie | 48 | $1,349 |
| UCB, Inc. | 62 | $1,286 |
| Mallinckrodt Hospital Products Inc. | 22 | $848 |
| Novartis | 29 | $526 |
| ANI Pharmaceuticals, Inc. | 16 | $439 |
| Radius Health, Inc. | 26 | $411 |
| Pfizer | 23 | $380 |
| AstraZeneca(2 entities) | 13 | $297 |
| E.r. Squibb & Sons, L.L.C. | 16 | $293 |
| GSK | 12 | $245 |
| Aurinia Pharma U.S., Inc. | 6 | $216 |
| Genentech USA, Inc. | 9 | $186 |
| Boehringer Ingelheim | 8 | $184 |
| Octapharma USA, Inc. | 3 | $69 |
| Organon | 2 | $53 |
| Almatica Pharma LLC | 2 | $52 |
| Lilly USA, LLC | 2 | $39 |
| Sanofi | 1 | $24 |
| Bioventus LLC | 1 | $21 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rinvoq$616
- Tremfya$518
- SIMPONI ARIA$518
- ACTHAR$415
- Bimzelx$373
- EVENITY$240
- PURIFIED CORTROPHIN GEL$174
- KRYSTEXXA$125
- Otezla$122
- LUPKYNIS$116
How this compares
$11,765 in reported general payments places this provider in the 95th percentile of 8,883 family providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxychloroquine Sulfate | 21 | $1,403 |
| Prednisone | 89 | $293 |
| Gabapentin | 17 | $258 |
| Allopurinol | 11 | $82 |
Paid to pharmacies, not to this prescriber.
Other family in Massapequa
- Christina NalboneNew York$197K
- Casey GrilloNew York$191K
- Suzanne WilsonIthaca$179K
- Jonathan LesuerSyracuse$172K
- Sheri HillNorth Syracuse$165K
- Cathrine CurtinBronxville$155K
- Mary Sullivan-WhalenNew York$137K
- Sarah AljahmiRockville Centre$87K
- John de OcaStaten Island$86K
- Fara StrickerGlen Oaks$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.